Zeng J - Search Results

1

Advances in postoperative adjuvant therapy for primary liver cancer.

Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Zeng ZM, et al. Among authors: zeng j. World J Gastrointest Oncol. 2022 Sep 15;14(9):1604-1621. doi: 10.4251/wjgo.v14.i9.1604. World J Gastrointest Oncol. 2022. PMID: 36187393 Free PMC article. Review.

2

Inflammatory myofibroblastic tumor of the prostate after transurethral resection of the prostate with negative expression of anaplastic lymphoma kinase: a case report.

Zeng J, He RQ, Mo WG, Peng ZG, Ma J, Zhong JC, Mo CH, Qin MJ, Hu XH. Zeng J, et al. Sao Paulo Med J. 2018 Sep-Oct;136(5):484-487. doi: 10.1590/1516-3180.2017.0079070417. Epub 2018 Jun 4. Sao Paulo Med J. 2018. PMID: 29898011 Free PMC article.

3

Efficacy and biomarker exploration of camrelizumab combined with apatinib in the treatment of advanced primary liver cancer: a retrospective study.

Zeng Z, Jiang Y, Liu C, Zhu G, Ma F, Yang L, Qiu J, Tang J, Ye X, Peng T, Zeng J, Ma J. Zeng Z, et al. Among authors: zeng j. Anticancer Drugs. 2021 Nov 1;32(10):1093-1098. doi: 10.1097/CAD.0000000000001127. Anticancer Drugs. 2021. PMID: 34232941

4

Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis.

Jiang Y, Zeng Z, Zeng J, Liu C, Qiu J, Li Y, Tang J, Mo N, Du L, Ma J. Jiang Y, et al. Among authors: zeng z, zeng j. Front Oncol. 2021 Sep 28;11:736113. doi: 10.3389/fonc.2021.736113. eCollection 2021. Front Oncol. 2021. PMID: 34650920 Free PMC article.

5

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma.

Wu M, Wu Z, Yan J, Zeng J, Kuang J, Zhong C, Zhu X, Mo Y, Guo Q, Li D, Tan J, Zhang T, Zhang J. Wu M, et al. Among authors: zeng j. Front Oncol. 2023 Jun 23;13:1198746. doi: 10.3389/fonc.2023.1198746. eCollection 2023. Front Oncol. 2023. PMID: 37427142 Free PMC article.

6

Smooth muscle actin immunostain is useful for the diagnosis of Trichomonas vaginalis in vaginal smears.

Fang N, Tang D, Zhang H, Zeng J. Fang N, et al. Among authors: zeng j. Diagn Cytopathol. 2021 Sep;49(9):1052-1055. doi: 10.1002/dc.24822. Epub 2021 Jul 22. Diagn Cytopathol. 2021. PMID: 34291890

7

Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.

Liu Z, Zhong J, Zeng J, Duan X, Lu J, Sun X, Liu Q, Liang Y, Lin Z, Zhong W, Wu W, Cai C, Zeng G. Liu Z, et al. Among authors: zeng g, zeng j. Front Immunol. 2021 Aug 31;12:735170. doi: 10.3389/fimmu.2021.735170. eCollection 2021. Front Immunol. 2021. PMID: 34531875 Free PMC article.

8

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer.

Zeng J, Chen J, Li M, Zhong C, Liu Z, Wang Y, Li Y, Jiang F, Fang S, Zhong W. Zeng J, et al. Front Pharmacol. 2023 May 24;14:1191129. doi: 10.3389/fphar.2023.1191129. eCollection 2023. Front Pharmacol. 2023. PMID: 37292153 Free PMC article.

9

The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer.

Liu L, Xiao W, Zhang C, Fan P, Zeng J, Yi J. Liu L, et al. Among authors: zeng j. Int J Gen Med. 2024 Mar 28;17:1233-1251. doi: 10.2147/IJGM.S454421. eCollection 2024. Int J Gen Med. 2024. PMID: 38562210 Free PMC article.

10

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas.

Xiao G, Xu X, Chen Z, Zeng J, Xie J. Xiao G, et al. Among authors: zeng j. Clin Med Insights Oncol. 2023 Sep 22;17:11795549231199915. doi: 10.1177/11795549231199915. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 37744424 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,089 results

Search Page